Login to Your Account

Rare Pulmonary Fibrosis may Have Blockbuster Potential

By Catherine Hollingsworth

Monday, June 23, 2008
A handful of companies are working to develop a treatment for a rare lung disorder called pulmonary fibrosis that, by some estimates, could present a $500 million to $1.5 billion market opportunity. (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription